v3.26.1
Capital Stock Repurchase Plan Transactions
6 Months Ended
Jun. 30, 2026
Capital Stock Repurchase Plan Transactions [Abstract]  
Capital Stock Repurchase Plan Transactions


14.    Capital Stock Repurchase Plan Transactions

We repurchased the following capital stock:

Three months ended June 30,

Six months ended June 30,

2026

2025

2026

2025

Total cost of repurchased shares (in thousands)

$

89,839 

$

42,945 

$

287,521 

$

72,701 

Shares repurchased

210,000 

75,000 

710,000 

125,000 

Weighted average price per share

$

427.81 

$

572.61 

$

404.96 

$

581.62 

In February 2026, the Board of Directors authorized $300.0 million for additional stock repurchases under Chemed’s existing share repurchase program. We currently have $139.8 million of authorization remaining under this share repurchase plan.